Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

81.37
Delayed Data
As of Sep 23
 -0.15 / -0.18%
Today’s Change
76.67
Today|||52-Week Range
111.11
-19.59%
Year-to-Date
Is This Tiny Company the Best Pharmacy Stock to Buy?
8:08am / MotleyFool.com - Paid Partner Content
The Cheapest Stocks in Biotech
Sep 23 / MotleyFool.com - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
8:01am / MotleyFool.com - Paid Partner Content
Gilead Sciences Inc.'s Biggest Win in 2016 So Far
Sep 22 / MotleyFool.com - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
Gilead Sciences (GILD) Stock Lower Despite Bullish Gabelli Note
Sep 22 / TheStreet.com - Paid Partner Content
Gilead (GILD) Stock Higher, Citigroup: Hepatitis C Drug Sales Improving
Sep 23 / TheStreet.com - Paid Partner Content
The Pros and Cons of Buying Gilead Sciences Stock
Sep 22 / MotleyFool.com - Paid Partner Content
7 Best Roth IRA Stocks for 2017
Sep 23 / MotleyFool.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close81.52
Today’s open81.55
Day’s range81.22 - 82.00
Volume7,534,538
Average volume (3 months)10,053,645
Market cap$107.4B
Dividend yield2.31%
Data as of 4:14pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-6.69%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+28.71%
P/E ratio7.2
Price/Sales4.80
Price/Book6.24

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-0.82-0.47%
BIIBBiogen-2.23-0.71%
ILMNIllumina Inc-0.01-0.01%
NBIXNeurocrine Bioscienc...-0.22-0.41%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$2.88
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts

Search for Jobs